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1. Introduction 
Spinal cord Sarcoidosis was first described by Longcope in 1941 (Longcope, 1941), and since 
then, spinal cord involvement has been reported in less than 10% of patients with 
neurosarcoidosis (Bogousslavsky et al., 1982, Fried et al., 1993) Spinal cord sarcoidosis is a 
chronic, granulomatous, systemic inflammatory disease, although precise understanding of 
the pathogenesis remains unclear, and most commonly occurs at the cervical level, presenting 
with subacute or chronic myelopathy frequently progressing to paraplegia (Sauter et al., 1991, 
Morita et al., 1992). The mainstay of treatment of spinal cord sarcoidosis is high-dose 
corticosteroid therapy, and surgery is undertaken when suggested by biopsy results and 
histopathological diagnosis (Jallo et al., 1997). However, since the lower middle cervical 
segments are more frequently affected (Nagai et al., 1985), it is difficult to differentiate cervical 
spinal cord sarcoidosis from cervical spondylotic myelopathy when gradually occurring in 
elderly patients. Magnetic resonance imaging (MRI) findings with high signal intensity on T2 
weighted images and vagueness of diffuse enlargement of the spinal cord due to spinal canal 
stenosis often leads to the surgeons to diagnose spinal cord sarcoidosis only after 
decompressive surgery has been performed for compressive cervical myelopathy. 
More than 80 cases of spinal cord sarcoidosis have been reported, most of which were studied 
using MRI (Kanzaki et al., 2004). There are no papers on the coexistence of compressive 
cervical myelopathy and cervical spinal cord sarcoidosis, and it is uncertain not only whether 
compressive cervical myelopathy triggers the development of inflammatory granuloma in 
spinal cord sarcoidosis but also the effect of decompressive surgery. In this chapter, the 
outcome of decompressive surgery performed for cervical spinal cord sarcoidosis 
accompanied with compressive cervical myelopathy and the effect of steroid therapy provided 
after decompressive surgery is expressed, comparing the outcome of the treatment of spinal 
cord sarcoidosis with no compressive cervical myelopathy shown by MRI. 
2. Diagnosis 
Nagoya Spine Group (NSG) was established since April 2006 by the spine surgeons of Nagoya 
University Hospital and 15 referral hospitals to evaluate the outcome of surgical treatment of 
spinal disorders in a prospective and/or retrospective multicenter clinical series. The NSG 
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database included 6,187 cases of patients who underwent spinal surgery, of which 1,560 cases 
were of compressive cervical myelopathy treated with cervical laminectomy or laminoplasty 
from January 2001 to December 2005. Of the 1,560 patients, a total of 12 (0.08%) patients were 
identified with spinal cord sarcoidosis, which was treated with decompressive surgery during 
the study period. The medical records of these 12 patients were retrieved, and the 
demographic data collected included age, sex, duration of disease, surgical outcome, and 
effectiveness of steroid therapy. The study was independently reviewed and approved by the 
institutional review boards at all participating institutions.  
The medical records of the patients were reviewed. The patients comprised 5 men and 7 
women, in the age range of 47 to 74 years (median, 57.8 years). Postoperative follow-up 
period ranged from 1 to 5 years (median, 2.0 years). Preoperative MRI was performed in all 
the cases and all lesions were observed to be present in the cervical region. Surgical outcome 
was evaluated using the Japanese Orthopaedic Association (JOA) scoring system, the JOA 
score was established prospectively at the time of treatment. This score comprises a total of 
17 points; 4 points each for motor dysfunction of the upper and lower extremities, 
respectively; 2 points each for sensory dysfunction of the upper and lower extremities and 
the trunk, respectively; and 3 points for bladder dysfunction. The recovery rate was 
calculated using Hirabayashi’s method.  
Zajicek’s diagnostic criteria (Zajicek et al., 1999), those of “definite”, “probable”, and 
“possible” were adopted for neurosarcoidosis. In brief, neurosarcoidosis was defined as 
“definite” when histopathological findings showed sterile, noncaseating granuloma in the 
spinal cord tissue. Neurosarcoidosis was defined as “probable” in the case of presence of 
spinal cord inflammation (elevated cerebrospinal fluid (CSF) protein level and/or increased 
cell number or spinal cord MRI findings comparable with those indicating 
neurosarcoidosis). Neurosarcoidosis was defined as “possible” when suggested by clinical 
presentation. After surgery, the diagnosis of neurosarcoidosis was confirmed, and the 
duration between the diagnosis and surgery ranged from 0 to 6 months (median, 3.9 weeks). 
3. Treatment 
3.1 Surgical treatment 
 All the 12 patients underwent decompressive surgery, including laminectomy (2 patients) 
and laminoplasty (10 patients). Preoperative diagnosis was intramedullary spinal cord 
tumor with compressive cervical myelopathy in 8 cases and cervical spondylotic 
myelopathy in 4 cases. That is all patients had compressive cervical myelopathy and spinal 
canal stenosis, with intramedullary T2 hyperintensity extending to the cervical level on MRI. 
The duration between the onset of initial symptoms and the operation ranged from 3 weeks 
to 1.5 years (median 7.3 months). Spinal cord biopsy was performed with the intraoperative 
motor-evoked potential (MEP) monitoring in 8 cases because intramedullary lesion was 
suspected on preoperative MRI or intraoperative ultrasonography; in the other 4 cases, only 
decompressive surgery was performed owing to the preoperative diagnosis of cervical 
spondylotic myelopathy. Radical surgical removal of the intramedullary sarcoid granuloma 
was possible only in 1 case. 
3.2 Steroid therapy 
All the 12 patients were provided high-dose corticosteroid therapy postoperatively. The 
duration between the operation and initiation of steroid administration ranged from 1 week 
www.intechopen.com
 Spinal Cord Sarcoidosis Accompanied with Compressive Cervical Myelopathy 
 
241 
to 3 months (median, 31.3 days). The effect of the steroid administred was evaluated on the 
basis of the JOA score. As control subjects, 8 patients with spinal cord sarcoidosis but 
showing no compressive lesion on MRI and who received high-dose steroid therapy from a 
neurologist without surgery were recruited to compare the effectiveness of the steroid and 
the outcome of spinal cord sarcoidosis. Their demographic data are presented in Table 1. 
The JOA score assigned of the non-surgery group was calculated on the basis of the 
retrospective review of the charts of the patients. There were no significant differences in the 
initial dose of the corticosteroid between the surgery and the non-surgery groups. 
 
 Surgery group (N=12)  Non-surgery group (N=8) 
Age (years) 57.8±9.8 62.4±8.2 
Gender (M/F) 5/7 2/6 
Follow-up period (month) 24.0±15.2 30.2±15.0 
Period from onset to surgery (week) 17.6±5.7 ― 
Period from onset to steroid (day) 44.9±15.9 43.5±12.8 
Initial dose of steroid (mg/day) 54.0±7.0 51.3±4.2 
JOA score before treatment (point) 8.2±2.4 8.9±2.4 
Table 1. Demographics of surgery and non-surgery group 
Non-surgery group indicates the patients with spinal cord sarcoidosis without compressive 
cervical myelopathy on MRI finding who underwent steroid therapy without operation. 
3.3 Statistical analysis 
StatView 5.0 software (ABACUS, Berkeley, CA) was used to calculate the statistical 
difference. Equality of means for continuous variables was assessed by using the Mann-
Whitney test. A P value of 0.05 or less was considered to be statistically significant. 
4. Results 
In the surgery group, 8 and 4 patients were identified with definite and probable 
neurosarcoidosis, respectively after decompressive surgery. The diagnosis in all the 8 cases 
of definite neurosarcoidosis was confirmed by biopsy results. The other 4 cases of probable 
neurosarcoidosis were diagnosed by a neurologist on the basis of laboratory data for 
inflammation of the spinal cord and biopsy of the lung, skin or eye. Spinal cord sarcoidosis 
was preoperatively suspected in 4 patients; however, they all showed negative results on 
clinical examination and other tissue biopsies. In the non-surgery group, all the 8 patients 
were diagnosed by a neurologist as having probable neurosarcoidosis without performing 
spinal cord biopsy. 
4.1 Clinical presentation 
There were no acute spinal cord symptoms that progressed within 1 month in both the surgery 
and the non-surgery groups. The characteristic spinal cord symptoms included chronic 
symptoms, which progressed over 3 months in 7 (58.3%) and 6 patients (75.0%) in the surgery 
and non-surgery groups, respectively, and subacute symptoms, which progressed within 3 
months in 5 (41.7%) and 2 patients (25%) in the surgery and non-surgery groups, respectively. 
All the patients in both the groups presented with insidious paresthesias in the extremities. In 
the surgery group, a discrepancy was observed between the narrowest portion and the 
neurological findings in the case of 7 (58.3%) patients. Other presentations such as hand 
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clumsiness, gait disturbance, and bladder dysfunction in both the groups are shown in Fig. 1. 
The surgery group exhibited a slight tendency to show serious neurological findings; however, 
there were no significant differences between the 2 groups. 
 
 
Fig. 1. Neurological symptoms 
4.2 MRI findings 
All the patients had fusiform enlargement of the spinal cord with high signal intensity on 
T2-weighted images and enhancing lesions in the spinal cord. Meningeal patchy 
enhancement occurred in 4 cases (33.3%) and 3 cases (37.5%) in the surgery and non-surgery 
groups, respectively. In the surgery group, high signal intensity on T2-weighted images 
extended from C2 to Th1, and the maximum compression levels were present in the high 
signal intensity area. Enhancing lesions were observed at C5-6 in 7 cases, C6-7 in 2 cases, 
C4/5 in 1 case, C2/3-Th1 in 1 case and C3/4-C6 in1 case, which coincided with the 
maximum compression levels observed in all the cases. (Fig.2) 
 
 
                                    High signal intensity on T2-weighted image 
                 The maximum compression level 
                 Enhancing lesion 
Fig. 2.  The distribution of the affected spinal segments. 
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4.3 Surgical outcome 
Preoperative JOA score in the surgery group was 8.2 points (2.0-11.0 points), and that in the 
non-surgery group was 9.0 points (5.0-13.0 points), with no significant differences. (p=0.52) 
Postoperative JOA score in the surgery group slightly decreased at 1 week and 4 weeks, and 
postoperative recovery rates in the surgery group at 1 week and 4 weeks were -7.4% (from -
52.9% to 25.0%) and -1.1% (from -41.2% to 25.0%), respectively (Fig.3). Only 5 of the 12 
patients showed clinical improvement after decompressive surgery, but their condition 
worsened again at an average of 7.4 weeks (2-12 weeks) after surgery. The average 
postoperative recovery rate of these 5 patients at 4 weeks was in 17.4% (9.5%-25.0%). After 
surgery, these 5 patients showed reduction in high signal intensity on T2-weighted images 
and enhancing lesions in the spinal cord; however, the improvement in MRI findings was 
not always consistent with neurological improvement. Only 2 of the 5 patients who showed 
temporary neurological improvement showed regression of the intramedullary sarcoid 
lesions. There was no correlation between the MRI findings after decompressive surgery 
and the clinical results.  
As postoperative complications, C5 palsy and infection were seen in 1 patient each. Sensory 
deterioration was seen in 4 of the 8 patients who underwent spinal cord biopsy. No motor 
deterioration was seen immediately after surgery except in 1 case of C5 palsy. No abnormal 
wave patterns on MEP monitoring were observed during biopsy as well as the whole 
procedure in any patient who underwent spinal cord biopsy. 
 
 
Fig. 3. JOA scores before and after each treatment 
4.4 Effect of steroid therapy  
Postoperative diagnosis of spinal cord sarcoidosis was made on the basis of pathological 
findings of the spinal cord in 8 patients, lung biopsy results in 2 patients, skin biopsy 
findings in 1 patient, and eye biopsy results in 1 patient at an average of 3.9 weeks (1-24 
weeks). Postoperative oral steroid therapy was initiated at an average of 6.4 weeks (2-25 
weeks), and the average initial dose was 54.0 mg (40-60 mg) in the surgery group and 51.3 
mg (30-60 mg) in the non-surgery group. There was no statistical significance in the initiated 
dose between the 2 groups. No patients were provided steroid therapy before 
decompressive surgery in the surgery group. Two patients in the surgery group died of 
another disease irrelevant to spinal cord sarcoidosis at 1 year and 22 months. The JOA score 
before steroid therapy, at 4 weeks and 1 year after steroid therapy and the recovery rate at 
the final follow-up are shown in Fig. 4 and Fig.5. Significant differences were observed in 
the JOA scores at 4 weeks and 1 year after steroid therapy. (p<0.05) At the final follow-up, 
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the recovery rate of the JOA score, which increased after steroid therapy, was significantly 
higher in the non-surgery group (62.5%) than in the surgery group (18.6%) (p<0.01). 
 
 
Fig. 4. JOA score before and after steroid administration. 
 
 
Fig. 5. Recovery rate in JOA score after steroid administration.  
4.5 Representative case (Fig.6) 
A 63-year-old woman presented with an 8 year history of gradual progression of numbness 
in the upper and lower extremities, bilateral hand clumsiness, gait disturbance and bladder 
dysfunction. MRI showed spinal cord compression and T2 hyperintensity extending from 
C4/5 to C5/6. Gadolinium enhancement was seen at the same levels as those of 
compression in sagittal slice and of multiple white-matter lesions in axial slice. Spinal cord 
sarcoidosis was suspected but other investigations including lymph node biopsy and 
bronchoalveolar lavage fluid analysis showed no abnormality. Anterior 
decompression/corpectomy should be reasonable for anterior compression and slight 
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kyphosis at C4/5 observed on MRI; however, posterior approach was adopted. After 
laminoplasty from C3 to C7 and spinal cord biopsy, the patient’s numbness and motor 
dysfunction were slightly reduced for 2 weeks, but T2 hyperintensity and gadolinium 
enhancement increased. After diagnosis of spinal cord sarcoidosis on the basis of 
pathological findings of the spinal cord, high-dose corticosteroid therapy (60mg) was 
initiated. Improvement was observed in the symptoms and MRI findings, but motor 
dysfunction persisted in the hands. 
 
   
 
    
Fig. 6. Representative case (63 years, female). A. Preoperative MRI showing spinal cord 
compression at C4/5 and T2 hyperintensity and gadolinium enhancement at C5. B. 
Postoperative MRI showing extended T2 hyperintensity and gadolinium enhancement. C. 
After administration of corticosteroid, T2 hyperintensity and gadolinium enhancement 
remarkably improved. 
5. Discussion 
Histopathogenesis of sarcoidosis of the central nervous system is considered as the flow of 
primary leptomeningeal inflammatory exudate from the subarachnoid space along the 
Virchow-Robin spaces into the brain parenchyma (Mirfakhraee et al., 1986). It remains 
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unknown if this hypothesis applies to spinal cord sarcoidosis; however, inflammatory 
granuloma formation and progressive fibrosis caused by immunological reaction play an 
important role (Newman et al., 1997). Clinical diagnosis of spinal cord sarcoidosis is often 
difficult since the nervous system is a relatively uncommon site for the occurrence of the 
disease. Biopsy of the nervous system tissue is required for definite diagnosis of 
neurosarcoidosis, and Zajicek et al. proposed definite diagnosis of the disease on the basis of 
positive histological findings of the nervous system (Zajicek et al., 1999). Unfortunately, 
biopsy is not possible or desirable in many cases because of the site of involvement. A 
presumptive diagnosis of sarcoidosis can be made on the basis of clinical or imaging 
evidence such as MRI findings, CSF angiotensin-converting enzyme (ACE) level, increased 
lysosome count and raised beta 2-microglobulin level, an increased helper-suppresor T-
lymphocyte ratio, or a CD4/CD8 ratio of >5 (Joseph et al., 2007). A comprehensive search 
for any systematic feature is required for the diagnosis of sarcoidosis after clinical 
confirmation of neurological involvement. 
 On the other hand, it is well known that while increased pressure within the spinal cord 
and sequential hypoxia and ischemic changes play important roles in the progression of 
lesions in cervical spondylotic myelopathy (Ito et al., 1996), involvement of inflammatory 
processes has also been indicated (Frank et al., 1995, Demircan et al., 2007). It is uncertain 
whether compressive cervical myelopathy triggers the development of inflammatory 
granuloma in spinal cord sarcoidosis. In the present study, MRI findings showed that area 
of enhancing sarcoid lesions coincided with the maximum compression levels. However, 
further study should be conducted to identify the relation between compressive myelopathy 
and lesions in sarcoidosis.  
 Diagnosis of sarcoidosis is expected to be difficult when the disease id accompanied with 
spinal cord compression due to cervical spondylosis; however, in this regard, a few reports 
are available. Ando et al. mentioned that spinal cord swelling without serious compression 
and disagreement between the level of compression and the extent of T2 hiperintensity 
challenge the presence of sarcoidosis (Ando et al., 2006). The present study demonstrated 
that the maximum compression levels in cervical spondylotic myelopathy coincided with 
the area of enhancing lesions, resulting in the inability to identify as sarcoidosis on the basis 
of MRI findings. Another study reported that inconsistency between the area with sensory 
disturbance and the affected level in cervical spondylotic myelopathy responsible for the 
main functional disorder enables differentiation (Oe et al., 2006). The fact that a discrepancy 
was observed between the narrowest portion and neurological findings in 58.3% patients 
indicates the difficulty in discriminating the affected levels in spinal cord sarcoidosis, 
especially in cases with multilevel stenosis. In addition, MRI findings concerning clinically 
silent compression of the spinal cord in elderly patients and the difficulties encountered in 
determining the exact responsible level in multisegmental compression (Boden et al., 1990) 
prompt many surgeons to perform multisegmental decompression by laminoplasty 
(Yonenobu et al., 1992, Satomi et al., 1994, Seichi et al., 2001). Neurological findings would 
not be reliable for diagnosis when spinal cord sarcoidosis develops at the level of stenosis. 
 Decompressive surgery produced temporary improvement in the condition of one-third of 
the patients with spinal cord sarcoidosis accompanied with compressive cervical 
myelopathy. However, the neurological symptoms relapsed postoperatively after a few 
months, and all the patients were provided steroid therapy. Spinal cord biopsy would have 
affected sensory deterioration immediately after surgery. In the previous study, 
neurological changes secondary to spinal cord biopsy occurred in 6 of 38 patients who 
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underwent biopsy; further, all postoperative complications were all mild and completely 
resolved in most cases at 3 months after surgery (Cohen-Gadol et al., 2003). Gradual 
neurological deterioration after decompressive surgery indicates insufficient decompression 
for lesions in sarcoidosis. In general surgical results of laminoplasty for cervical spondylotic 
myelopathy have been shown to be good, helping to prevent neurological deterioration and 
resulting in 50%-70% recovery rates (Sakai et al., 2005, Yukawa et al., 2007). The present 
study demonstrated that the average recovery rate of the patients who showed neurological 
improvement after surgery was 17.4%, which was extremely lower than that observed in 
cervical spondylotic myelopathy; further, the improvement was only transitory.  
 While steroid administration after decompressive surgery was shown to be effective for 
spinal cord sarcoidosis accompanied with compressive cervical myelopathy, the outcome 
was poorer than that of the treatment of spinal cord sarcoidosis without compressive 
cervical myelopathy. This may be ascribed to the irreversible change produced in the spinal 
cord due to mechanical compression. In spinal cord sarcoidosis accompanied with 
compressive cervical myelopathy, decompressive surgery including laminoplasty should 
not be the first choice of treatment except for cases with appropriate differentiation of 
intramedullary spinal cord tumor and early diagnosis of sarcoidosis. Although there are no 
distinct signal characteristics for spinal cord sarcoidosis, diffuse increase in intramedullary 
T2 hyperintensity, presence of enhancing nodules, and leptomeningeal involvement suggest 
the disease. The mainstay of medical treatment of spinal cord sarcoidosis is steroid therapy, 
thus, it should be preferred after early diagnosis rather than decompressive surgery. 
Postoperative neurological deterioration after resection of sarcoid granulomas has been 
reported (Day et al., 1977, Baruah et al., 1978). Mathieson et al demonstrated that among 31 
cases of histologically proven intramedullary sarcoidosis, postoperative deterioration in 
neurological function occurred in 50% cases (Mathieson et al., 2004). Thus, several reports 
suggest that the first surgery should be limited to decompression of the spinal cord and 
biopsy without complete extirpation in cases of suspected spinal cord sarcoidosis 
(Rubinstein et al., 1984, Vighetto et al., 1985, Kayama et al., 1993Jallo et al., 1997, Yukawa et 
al., 1999). However, there has been no report describing the effects of spinal cord 
decompression on lesions in sarcoidosis. In spinal cord sarcoidosis accompanied with 
compressive cervical myelopathy such as in our series, it is difficult to determine which 
lesion is responsible for the neurological symptoms. Early treatment with a suitable steroid 
decreases inflammation in sarcoidosis (Soucek et al., 1993) and MRI findings are 
dramatically improved by corticosteroid therapy (Koike et al., 2000). A long interval 
between the onset of the disease and the initiation of steroid therapy contributes to poor 
functional recovery (Stern et al., 1985). Decompressive surgery should be undertaken when 
steroid therapy proves to be insufficient for the treatment of spinal cord sarcoidosis 
accompanied with cervical compressive myelopathy. In addition in cases with 
unsatisfactory results of decompressive surgery for compressive cervical myelopathy, 
presence of spinal cord sarcoidosis should be considered, if spinal cord swelling and/or 
increase in intramedullary T2 hyperintensity are observed after decompression. In some 
cases, enlarged spinal cord appears unclear with coexisting compressive cervical lesions. 
Spinal cord enlargement is occasionally underestimated when cervical spondylotic 
compression coexists. Spinal cord biopsy is indispensable if the diagnosis of sarcoidosis is 
not proved; however, the risks involved in performing biopsies for nonspecific spinal cord 
lesions may lead to the preference for generalized screening and diagnosis of sarcoidosis on 
the basis of less invasive procedures before subjecting the patient to surgery. The patients 
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should be informed that the prognosis of surgery is guarded in any case of spinal cord 
sarcoidosis. 
6. Conclusions 
The effectiveness of decompressive surgery for spinal cord sarcoidosis accompanied with 
compressive cervical myelopathy is transitory and not adequate. Steroid therapy after 
decompressive surgery is also less effective for spinal cord sarcoidosis accompanied with 
compressive cervical myelopathy, compared with the treatment of spinal cord sarcoidosis 
without compressive cervical myelopathy. Early diagnosis of sarcoidosis and steroid 
therapy is preferred. 
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